TipRanks (Fri, 13-Feb 9:20 AM ET)
Aethlon Medical signals faster clinical trial enrollment amid Hemopurifier advancements
Seeking Alpha News (Thu, 12-Feb 10:15 PM ET)
Aethlon Medical Posts Q3 Results, Highlights Hemopurifier Progress
TipRanks (Thu, 12-Feb 5:04 PM ET)
Aethlon Medical GAAP EPS of -$2.45 misses by $0.03
Seeking Alpha News (Thu, 12-Feb 4:33 PM ET)
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
PRNewswire (Thu, 12-Feb 4:15 PM ET)
Aethlon Medical Q3 2026 Earnings Preview
Seeking Alpha News (Wed, 11-Feb 5:35 PM ET)
Here are the major earnings after the close Thursday
Seeking Alpha News (Wed, 11-Feb 10:00 AM ET)
PRNewswire (Wed, 4-Feb 8:01 AM ET)
PRNewswire (Fri, 5-Dec 9:15 AM ET)
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Aethlon Medical trades on the NASDAQ stock market under the symbol AEMD.
As of February 13, 2026, AEMD stock price declined to $1.96 with 38,493 million shares trading.
AEMD has a beta of 1.31, meaning it tends to be more sensitive to market movements. AEMD has a correlation of 0.03 to the broad based SPY ETF.
AEMD has a market cap of $1.91 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, AEMD traded as high as $576.00 and as low as $1.86.
AEMD has underperformed the market in the last year with a price return of -96.1% while the SPY ETF gained +13.0%. AEMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -58.6% and -21.6%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
AEMD support price is $1.84 and resistance is $2.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEMD shares will trade within this expected range on the day.